Braden Michael Leonard
CIK 1373603 · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$168.31M
Companies
16
Total Filings
110
Lifetime Open-Market Net
-$13.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OM | 10%+ Owner | 2,519,701 | $4.49 | $11.31M | $0 | 2 | 2026-05-18 |
| ACRS | 10%+ Owner | 13,950,000 | $4.32 | $60.26M | $4.23M | 8 | 2026-04-27 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | 10%+ Owner | 2,149,880 | $4.36 | $9.37M | $1.41M | 11 | 2025-12-05 |
| ASTC | 10%+ Owner | 0 | $19.01 | $0 | -$815.2K | 8 | 2025-10-07 |
| ANTX | 10%+ Owner | 3,017,432 | $4.74 | $14.30M | -$1.53M | 3 | 2025-06-16 |
| OKUR | 447,815 | $4.20 | $1.88M | $0 | 1 | 2024-10-09 | |
| OnKure Therapeutics, Inc. (RPHM) Delisted | 10%+ Owner | 4,478,164 | $18.20 | $81.50M | $1.73M | 5 | 2024-09-26 |
| Talis Biomedical Corp (TLIS) Delisted | 10%+ Owner | 217,951 | $2.84 | $619.0K | $56.1K | 1 | 2024-08-28 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | 10%+ Owner | 4,871,380 | $16.80 | $81.84M | $971.5K | 1 | 2024-05-15 |
| IMRA | 10%+ Owner | 1,997,774 | $17.02 | $34.00M | -$9.40M | 9 | 2023-01-05 |
| RVP | 10%+ Owner | 1,076,075 | $0.70 | $752.9K | -$2.08M | 7 | 2022-12-29 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 6,760,570 | $0.49 | $3.35M | $936.1K | 4 | 2022-12-21 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | 10%+ Owner | 6,590,000 | $1.10 | $7.25M | $4.50M | 2 | 2022-11-23 |
| Disc Medicine, Inc. (GMTX) Delisted | 10%+ Owner | 5,247,500 | $13.50 | $70.84M | $1.29M | 2 | 2022-10-27 |
| BBW | 1,423,043 | $32.13 | $45.72M | -$11.65M | 33 | 2017-10-02 | |
| PRPH | 10%+ Owner | 627,322 | $0.11 | $69.0K | -$3.16M | 7 | 2017-10-02 |
Recent Filings · Page 2 of 11
110 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-24 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +350,000 | $1.05M | EDGAR |
| 2025-04-02 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +34,775 | $147.1K | EDGAR |
| 2025-03-27 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +3,814 | $16.8K | EDGAR |
| 2025-03-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +117,941 | $587.6K | EDGAR |
| 2025-02-28 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +336,756 | $1.44M | EDGAR |
| 2024-10-09 | OKUR | Other (J) | +447,815 | $0 | EDGAR |
| 2024-09-26 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +98,346 | $144.7K | EDGAR |
| 2024-09-19 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +56,106 | $76.2K | EDGAR |
| 2024-09-16 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +358,923 | $484.3K | EDGAR |
| 2024-09-09 | — | Buy (P) | +30,100 | $44.2K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.